Phase 2 Study of TXA127 in Post-ischemic Stroke Patients

TXA127, a pharmaceutically formulated angiotensin (1-7) heptapeptide, identical to the endogenously produced, non-hypertensive derivative of angiotensin II (Ang II) is a sterile solution containing angiotensin (1-7) \[A(1-7)\], supplied in a 3 mL, single-use, stoppered vial.

Placebo is a sterile solution containing supplied in a 3 mL, single-use, stoppered vial.